@RBR I think the AGM will be a more cordial affair than the past 5 years due to the 1st qrt update. I am not expecting a 4 monthly trading update as has been the case under the previous CEO (it never made a lot of sense to me). I think quarterly updates make more sense. I am hoping to see some positive commentary about : 1. continued improvement in sales of Nextellis and the rest of the WH products. Recommit to December breakeven for Nextellis 2. Capital management in better shape than for the 1st qrt 3. Continued improvement in Dermatology (Rhofade sales apparently are already at the levels reached by previous owner in only 3 weeks)
If positive commentary continues at the AGM, I think the shares will continue rising until the 1st half update in February 2024. Cheers
MYX Price at posting:
$4.99 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)